- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06001944
Investigation of the Efficacy of Blood Flow Restricted Training in Lateral Elbow Tendinopathy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Fulya DEMIRHAN, PHd Student
- Phone Number: +90-532-353-2208
- Email: f.gurcenan@hotmail.com
Study Contact Backup
- Name: Yıldız ANALAY AKBABA, Assoc.prof.
- Phone Number: +90-532-377-4013
- Email: yildizanalay@yahoo.com
Study Locations
-
-
Büyükçekmece
-
Istanbul, Büyükçekmece, Turkey, No:5/9/1
- Recruiting
- Istanbul University - Cerrahpasa
-
Contact:
- Fulya DEMIRHAN, PHd Student
- Phone Number: +90-532-353-2208
- Email: f.gurcenan@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between 18 and 65 years of age,
- Lateral tendinopathy diagnosis,
- Have scored 33 or more out of 100 on the Patient Based Tennis elbow Assessment Test (PRTEE).
Exclusion Criteria:
- Dysfunction in the shoulder, neck and/or chest area,
- Local or generalized arthritis.
- The neurological deficit.
- Radial dysfunction,
- Limitation of arm functions,
- A history of shoulder or upper extremity pathology requiring surgery or treatment;
- Venous thromboembolism
- Inflammation or other hematological disorders.
- Coronary artery disease,
- Peripheral arterial disease or hypertension (systolic/diastolic blood pressure >140 mm Hg/90 mmHg),
- To be pregnant,
- Irritation of median nerves.
- Irritation of radial nerves.
- Irritation of the ulnar nerves,
- The pain score is less than 30 mm.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
8 weeks, 2 days a week, a multi-model rehabilitation program is implemented.
|
Patients with LDT will be informed that the condition will be gradually resolved with adequate rest and time. Exercise Training will consist of 3 phases.The goal is to protect the injured tissue from stress during the first phase of rehabilitation during the protective phase but not to restrict its function. In this phase, the use of counterforce breys, cold application, cyriax physiotherapy, Mill's manipulation, elbow mobilization and stretching to the wrist extensors will be applied. The program will be created taking into account the principle of proximal stability for distal mobility during the reinforcement phase. The rotator manchet will be added to the program. It will be active first in the exercise and then progresses resistantly according to the condition of the patient. After distal strengthening, the dress will be transferred to stabilization exercises where flexion and extension reveal simultaneous contraction. |
|
Experimental: Experimental group
8 weeks, 2 days a week, blood flow restriction during exercise will be applied in addition to the multi-model rehabilitation program.
The elbow will be placed near the elbow and the patient's systolic pressure will be used to restrict the blood flow with the recommended 40%-50% occlusion for the upper extremity, and the exercise intensity will be performed 75 times at 20-30% of 1 maximum repetition, 30-15-15-15 repetition and 30 seconds rest between sets.
|
The BFR training group will be given detailed information about the technique and discussed possible side effects.The American Association of Sports Physicians (ACSM) recommends that at least 65% of 1 maximum repetition, similar to high-intensity exercise, 8-12 repetitions of resistant weight lifting strength training, can be used with low loads such as 20% to 30% of the maximum 1 repetition in therapy to caste hypertrophy and strength.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
In the resting position, a 100 mm long line will be drawn and patients will be asked to mark the area where they express the severity of the pain on that line.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Painless Grip Strength
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
Average values of 3 repeated measurements with the Baseline dynamometer will be recorded while the patient is sitting upright, at shoulder adduction, at 90 degree flexion of the elbow, supported at the middle rotation of the front arm and while the wrist is in a neutral position.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Patient-rated tennis elbow evaluation (PRTEE)
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
It consists of two subheadings, pain and function.
Function subheadings include specific activities and general activities, and each subgroup takes a value from 0 to 10.
For the total score, the average of individual and general activity scores is collected with the total pain score.
The result is a value between 0 and 100.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF-12 Quality of Life Questionnaire
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
The SF-12 consist of 12 items assesing physical and mental health and yields 2 summary scores; the mental component summary and physical component summary.
Scoring is norm based with a mean of 50; higher scores indicate better health.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Global Rating of Change
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
Global rating of change scale quantifies a patient's improvement or deterioration over time, and identifies the effect of an intervention or charts the clinical course of a condition.
The patient selects between "much worse", "slightly worse", "stayed at same", "slightly better" and, "much better".
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Range of Motion
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
The range of motion clarity of the shoulder, elbow, front arm and wrist joints in resting position using the gonyometer will be tested.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Manual Muscle Testing
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
The upper, middle and lower trapezoidal muscles, serratus anterior, biceps brachii and triceps brachii will be evaluated.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
|
Pressure-Pain Threshold Measurement
Time Frame: Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
An algometer is a device consisting of a frame displaying the pressure to be applied to this piston with a metal piston containing a round disk of about 1 cm in diameter at the end.
The algometer will be asked to tell the patient the level of discomfort by pressing it at a straight angle to the most sensitive area in the lateral epicondyl area.
The pressure value for the pain sensation will be determined as the pain threshold and the values obtained in kilograms (kg) will be recorded.
|
Evaluation should be carried out at baseline, at the end of four weeks of the treatment, at the end of eight weeks of the treatment, and at the end of four weeks of follow-up
|
Collaborators and Investigators
Investigators
- Study Chair: Yıldız ANALAY AKBABA, Assoc. prof., Istanbul University - Cerrahpasa (IUC)
Publications and helpful links
General Publications
- Coombes BK, Bisset L, Vicenzino B. Management of Lateral Elbow Tendinopathy: One Size Does Not Fit All. J Orthop Sports Phys Ther. 2015 Nov;45(11):938-49. doi: 10.2519/jospt.2015.5841. Epub 2015 Sep 17.
- Karanasios S, Korakakis V, Moutzouri M, Xergia SA, Tsepis E, Gioftsos G. Low-Load Resistance Training With Blood Flow Restriction Is Effective for Managing Lateral Elbow Tendinopathy: A Randomized, Sham-Controlled Trial. J Orthop Sports Phys Ther. 2022 Dec;52(12):803-825. doi: 10.2519/jospt.2022.11211. Epub 2022 Sep 13.
- Kim YJ, Wood SM, Yoon AP, Howard JC, Yang LY, Chung KC. Efficacy of Nonoperative Treatments for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2021 Jan 1;147(1):112-125. doi: 10.1097/PRS.0000000000007440.
- Lenoir H, Mares O, Carlier Y. Management of lateral epicondylitis. Orthop Traumatol Surg Res. 2019 Dec;105(8S):S241-S246. doi: 10.1016/j.otsr.2019.09.004. Epub 2019 Sep 19.
- Ozdincler AR, Baktir ZS, Mutlu EK, Kocyigit A. Chronic lateral elbow tendinopathy with a supervised graded exercise protocol. J Hand Ther. 2023 Mar 11:S0894-1130(22)00113-2. doi: 10.1016/j.jht.2022.11.005. Online ahead of print.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 665912
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lateral Epicondylitis
-
Hospital for Special Surgery, New YorkCompletedLateral Epicondylitis | Lateral Epicondylitis, Unspecified Elbow | Lateral Epicondylitis, Left Elbow | Lateral Epicondylitis, Right Elbow | Lateral Epicondylitis (Tennis Elbow) Bilateral | Medial Epicondylitis | Medial Epicondylitis, Right Elbow | Medial Epicondylitis, Left ElbowUnited States
-
Centre Mutualiste de Rééducation et de Réadaptation...RecruitingLateral Epicondylitis of the ElbowFrance
-
Haseki Training and Research HospitalCompletedLateral Epicondylitis (Tennis Elbow)Turkey
-
Gaziler Physical Medicine and Rehabilitation Education...CompletedLateral Epicondylitis | Lateral Epicondylitis (Tennis Elbow)Turkey (Türkiye)
-
Singapore General HospitalNot yet recruitingLateral Epicondylitis, Unspecified Elbow
-
McMaster UniversityArthrex, Inc.; The Physicians' Services Incorporated Foundation; Radiological...TerminatedLateral Epicondylitis (Tennis Elbow)Canada, United States
-
Cairo UniversityRecruitingLateral Epicondylitis | Tennis Elbow | Lateral Epicondylitis, Unspecified ElbowLebanon
-
Konya Beyhekim Training and Research HospitalRecruitingLateral Epicondylitis (Tennis Elbow)Turkey
-
Siddharth Padia, MDRecruiting
-
University of CadizNot yet recruitingElbow Tendinopathy | Epicondylitis | Epicondylitis, Lateral | Epicondylitis of the Elbow
Clinical Trials on Multimodal rehabilitation
-
Karolinska InstitutetThe Swedish Research Council; Karolinska Institutet: Doctoral School in Health...UnknownChronic Pain | Widespread Chronic PainSweden
-
Uppsala UniversityCompletedChronic Pain | Complex Regional Pain SyndromesSweden
-
National Institute of Geriatrics, Rheumatology...CompletedComplex Regional Pain SyndromesPoland
-
Clínica INEBIRActive, not recruiting
-
PensionsversicherungsanstaltCompletedCrohn Disease | Ulcerative ColitisAustria
-
University of ValenciaCompletedEnhanced Recovery | Fast Track
-
Zhongnan HospitalRecruitingConcurrent Chemoradiotherapy;Nutrition;Multimodal RehabilitationChina
-
Università Politecnica delle MarcheCompleted
-
Balikesir UniversityCompletedAxial Spondyloarthritis (AxSpA)Turkey (Türkiye)
-
PensionsversicherungsanstaltCompleted